Response to Ponamgi et al. Comments on Khalighi et al. Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction. J. Cardiovasc. Dev. Dis., 2015, 2, 273–281.

Detalles Bibliográficos
Autores principales: Farooq, Mohammad Umar, Khalighi, Koroush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Reply
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715698/
https://www.ncbi.nlm.nih.gov/pubmed/29367556
http://dx.doi.org/10.3390/jcdd3010004
_version_ 1783283816116256768
author Farooq, Mohammad Umar
Khalighi, Koroush
author_facet Farooq, Mohammad Umar
Khalighi, Koroush
author_sort Farooq, Mohammad Umar
collection PubMed
description
format Online
Article
Text
id pubmed-5715698
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57156982018-01-19 Response to Ponamgi et al. Comments on Khalighi et al. Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction. J. Cardiovasc. Dev. Dis., 2015, 2, 273–281. Farooq, Mohammad Umar Khalighi, Koroush J Cardiovasc Dev Dis Reply MDPI 2016-01-26 /pmc/articles/PMC5715698/ /pubmed/29367556 http://dx.doi.org/10.3390/jcdd3010004 Text en © 2016 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Reply
Farooq, Mohammad Umar
Khalighi, Koroush
Response to Ponamgi et al. Comments on Khalighi et al. Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction. J. Cardiovasc. Dev. Dis., 2015, 2, 273–281.
title Response to Ponamgi et al. Comments on Khalighi et al. Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction. J. Cardiovasc. Dev. Dis., 2015, 2, 273–281.
title_full Response to Ponamgi et al. Comments on Khalighi et al. Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction. J. Cardiovasc. Dev. Dis., 2015, 2, 273–281.
title_fullStr Response to Ponamgi et al. Comments on Khalighi et al. Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction. J. Cardiovasc. Dev. Dis., 2015, 2, 273–281.
title_full_unstemmed Response to Ponamgi et al. Comments on Khalighi et al. Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction. J. Cardiovasc. Dev. Dis., 2015, 2, 273–281.
title_short Response to Ponamgi et al. Comments on Khalighi et al. Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction. J. Cardiovasc. Dev. Dis., 2015, 2, 273–281.
title_sort response to ponamgi et al. comments on khalighi et al. takotsubo cardiomyopathy: a long term follow-up shows benefit with risk factor reduction. j. cardiovasc. dev. dis., 2015, 2, 273–281.
topic Reply
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715698/
https://www.ncbi.nlm.nih.gov/pubmed/29367556
http://dx.doi.org/10.3390/jcdd3010004
work_keys_str_mv AT farooqmohammadumar responsetoponamgietalcommentsonkhalighietaltakotsubocardiomyopathyalongtermfollowupshowsbenefitwithriskfactorreductionjcardiovascdevdis20152273281
AT khalighikoroush responsetoponamgietalcommentsonkhalighietaltakotsubocardiomyopathyalongtermfollowupshowsbenefitwithriskfactorreductionjcardiovascdevdis20152273281

Ejemplares similares